Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 54465-54466 [2021-21396]

Download as PDF Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; Renal/ Urological Small Business Activities. Date: November 4, 2021. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Santanu Banerjee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2106, Bethesda, MD 20892, (301) 435–5947, banerjees5@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: SBIR/STTR Commercialization Readiness Pilot (CRP) Program. Date: November 4, 2021. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Allen Richon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301–379– 9351, allen.richon@nih.hhs.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Oncology. Date: November 4–5, 2021. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Reigh-Yi Lin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm. 4152, MSC 7846, Bethesda, MD 20892, (301) 827– 6009, lin.reigh-yi@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 27, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–21381 Filed 9–30–21; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:04 Sep 30, 2021 Jkt 256001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Recompetition of the Pediatric Scientist Development. Date: October 7, 2021. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2137B, Bethesda, MD 20892 (Video Assisted Meeting). Contact Person: Joanna Kubler-Kielb, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2137B, Bethesda, MD 20892, 301–435–6916, kielbj@ mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Developmental Mechanisms of Human Structural Birth Defects. Date: November 17–18, 2021. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2125B, Bethesda, MD 20892 (Video Assisted Meeting). Contact Person: Derek J. McLean, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 54465 6710B Rockledge Drive, Room 2125B, Bethesda, MD 20892–7002, 301–443–5082, derek.mclean@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.865, Research for Mothers and Children, National Institutes of Health, HHS) Dated: September 28, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–21397 Filed 9–30–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Developmental Biology Study Section. Date: October 15, 2021. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Bethesda, MD 20817 (Video Assisted Meeting). Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2121D, Bethesda, MD 20892–7510, (301) 435–6878, cathy.wedeen@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) E:\FR\FM\01OCN1.SGM 01OCN1 54466 Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices Dated: September 28, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–21396 Filed 9–30–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Refugee Resettlement Public/Private Refugee Cash Assistance Inflationary Increase Office of Refugee Resettlement (ORR), Administration for Children and Families (ACF), Department of Health and Human Services (HHS). ACTION: Notice of change in payment ceilings. AGENCY: In accordance with ORR regulations, the Director of ORR is announcing an inflationary increase to the public/private Refugee Cash Assistance (RCA) program’s monthly payment ceilings, effective October 1, 2021. The current payment ceilings have remained fixed since March 22, 2000, despite inflation. The new payment ceilings accommodate that inflation and will provide arriving ORReligible populations greater economic stability as they transition to selfsufficiency. SUMMARY: The changes described in this Federal Register Notice are effective October 1, 2021. FOR FURTHER INFORMATION CONTACT: Colleen Mahar-Piersma, Refugee Policy Unit, Division of Policy and Procedures, Office of the Director, Office of Refugee Resettlement, Administration for Children and Families, by phone at (202) 260–5493, and email at refugeepolicy@acf.hhs.gov. SUPPLEMENTARY INFORMATION: ORR-eligible populations are eligible for up to eight months of RCA after their initial ORR eligibility date if they are deemed ineligible for the Temporary Assistance for Needy Families (TANF) program. When TANF was established in 1996, ORR gave states the option to either establish a publicly administered RCA program modeled after their TANF program in terms of eligibility determinations and benefits levels, or the option to establish a public/private partnership (PPP) RCA program. States that chose the PPP RCA model proposed a plan to ORR that created their income eligibility standard and may have included sliding scale payments or incentives for early employment aimed at refugee self-sufficiency, as long as DATES: VerDate Sep<11>2014 18:04 Sep 30, 2021 Jkt 256001 they remained within the established payment ceilings. ORR established the PPP RCA monthly payment ceilings codified at 45 CFR 400.60(a) using the poverty guidelines developed by the Assistant Secretary for Planning and Evaluation within HHS. These poverty guidelines, which are updated annually, are mainly used for administrative purposes such as determining an individual’s eligibility for certain programs. When ORR established the current PPP RCA monthly payment ceilings, it used the 1998 HHS Poverty Guidelines with the following formula: ‘‘50% of the 1998 HHS Poverty Guidelines for each family size, divided by 12 months. . . .’’ Where family units were greater than four people, the monthly payment ceiling was increased by $70 for each additional person. These PPP RCA payment ceilings have remained fixed since March 22, 2000, despite inflation and an increased cost of living nationwide. The payment ceilings are insufficient to meet refugees’ initial expenses for housing, utilities, transportation, food, and other essentials, as they acclimate to their new communities and try to secure employment. Refugees generally have no other means of assistance such as savings or family resources to assist in the early days of arrival. Additionally, more than half of current projected ORR-eligible arrivals do not benefit from assistance from the Department of State’s Reception and Placement Program, making RCA a critical source of support as they strive for economic self-sufficiency and integration. As such, in accordance with ORR regulations at 45 CFR 400.60(d), the ORR Director has determined that the PPP RCA payment ceilings need to be adjusted for inflation. Using ORR’s original formula in relation to the 2021 HHS poverty guidelines, the adjusted PPP RCA payment ceilings are: administered programs. All remaining RCA programs must continue to follow their established TANF rate. To implement the RCA payment ceilings outlined in this Notice, the State/Replacement Designee (RD) must first revise its State Plan and ORR–1 CMA estimate. ORR will issue further guidance on how a State/RD should address implementation of the new public/private partnership RCA rate in its State Plan and ORR–1 prior to the implementation of the increased rate. ORR will also conduct minimally, a bi-annual review of the HHS Poverty Guidelines, the established PPP rates, and the availability of funding with the goal of enacting more responsive and equitable cash assistance rates in the public/private RCA program. (Authority: 45 CFR 400.60) Dated: September 24, 2021. Cindy Huang, Director of the Office of Refugee Resettlement. [FR Doc. 2021–21369 Filed 9–30–21; 8:45 am] BILLING CODE 4120–27–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing PUBLIC/PRIVATE RCA PAYMENT Programs using Urine or Oral Fluid CEILINGS (Mandatory Guidelines). FOR FURTHER INFORMATION CONTACT: Monthly Anastasia Donovan, Division of Size of family unit payment ceiling Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N06B, 1 ............................................ $537 Rockville, Maryland 20857; 240–276– 2 ............................................ 726 2600 (voice); Anastasia.Donovan@ 3 ............................................ 915 4 ............................................ 1,104 samhsa.hhs.gov (email). SUPPLEMENTARY INFORMATION: In accordance with Section 9.19 of the Where family units are greater than Mandatory Guidelines, a notice listing four people, the monthly payment all currently HHS-certified laboratories ceiling is increased by $113 for each and IITFs is published in the Federal additional person. These payment ceilings only apply to Register during the first week of each RCA recipients within PPPmonth. If any laboratory or IITF PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 SUMMARY: E:\FR\FM\01OCN1.SGM 01OCN1

Agencies

[Federal Register Volume 86, Number 188 (Friday, October 1, 2021)]
[Notices]
[Pages 54465-54466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21396]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group; Developmental Biology Study 
Section.
    Date: October 15, 2021.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Eunice Kennedy Shriver National Institute of Child Health 
and Human Development, National Institutes of Health, 6710B 
Rockledge Drive, Bethesda, MD 20817 (Video Assisted Meeting).
    Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, National Institutes 
of Health, 6710B Rockledge Drive, Room 2121D, Bethesda, MD 20892-
7510, (301) 435-6878, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)


[[Page 54466]]


    Dated: September 28, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-21396 Filed 9-30-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.